mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.01 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.01 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |
mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.01 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.12 |
0.01 |